| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
4,011 | 4,714 | 2,588 | 3,115 | 6,354 |
| Cost of Revenue
|
-15,051 | -1,226 | -1,019 | -1,438 | -647 |
|
Gross Profit
|
-11,040 | 3,488 | 1,569 | 1,677 | 5,707 |
| Selling, General and Administrative Expenses
|
-16,527 | -16,259 | -18,193 | -18,887 | -19,397 |
|
Research and Development Expenses
|
-3,380 | -- | -- | -- | -- |
| Depreciation, Amortization and Depletion
|
-7,445 | -7,445 | -8,222 | -8,146 | -7,879 |
| Other Income/Expense, Operating
|
306 | -11,253 | -8,671 | -16,264 | -17,331 |
|
Operating Income/Expenses
|
-19,601 | -34,957 | -35,086 | -43,297 | -44,607 |
|
Total Operating Profit/Loss
|
-30,641 | -31,469 | -33,517 | -41,620 | -38,900 |
| Total Net Finance Income/Expense
|
-223 | -431 | -724 | -2,488 | -1,372 |
|
Non-Operating Income/Expenses, Total
|
-223 | -431 | -724 | -2,488 | -1,372 |
|
Pretax Income
|
-30,863 | -31,900 | -34,241 | -44,108 | -40,272 |
|
Provision for Income Tax
|
0 | -- | -- | -- | -- |
|
Net Income from Continuing Operations
|
-30,863 | -31,900 | -34,241 | -44,108 | -40,272 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-30,863 | -31,900 | -34,241 | -44,108 | -40,272 |
|
Non-Controlling/Minority Interests
|
0 | -- | -- | -- | -- |
|
Net Income after Non-Controlling/Minority Interests
|
-30,863 | -31,900 | -34,241 | -44,108 | -40,272 |
|
Net Income Available to Common Stockholders
|
-30,863 | -31,900 | -34,241 | -44,108 | -40,272 |
|
Diluted Net Income Available to Common Stockholders
|
-30,863 | -31,900 | -34,241 | -44,108 | -40,272 |
| Basic EPS
|
-0.72 | -1.07 | -2.88 | -6.78 | -7.14 |
| Diluted EPS
|
-0.72 | -1.07 | -2.88 | -6.78 | -7.14 |
|
Basic Weighted Average Shares Outstanding
|
30,741.1380 | 21,610.8540 | 11,167.5920 | 5,890.2740 | 3,762.0080 |
|
Diluted Weighted Average Shares Outstanding
|
30,741.1380 | 21,610.8540 | 11,167.5920 | 5,890.2740 | 3,762.0080 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-30,640 | -31,469 | -33,517 | -41,620 | -38,900 |
|
EBITDA
|
-23,772 | -24,382 | -25,810 | -33,474 | -31,021 |
|
Normalized EBITDA
|
-23,772 | -24,382 | -25,810 | -33,474 | -31,021 |
|
Normalized Income
|
-30,863 | -31,900 | -34,241 | -44,108 | -40,272 |
|
Total Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Total Unusual Items Excluding Goodwill
|
0 | 0 | 0 | 0 | 0 |
12/31/2022 - 12/20/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade